EVFM - Why Is Life Sciences-Focused Aditxt Stock Trading Higher Today? | Benzinga
Aditxt Inc (NASDAQ: ADTX) has agreed to acquire Evofem Biosciences Inc (OTC: EVFM) in consideration of the issuance of a combination of common stock and preferred stock and the assumption of certain senior indebtedness, having an aggregate amount of approximately $100 million.
Evofem is a commercial-stage women's health company, a creator of the first and only FDA-approved hormone-free contraceptive gel, Phexxi (lactic acid, citric acid, and potassium bitartrate).
Phexxi represents a groundbreaking shift in women's healthcare, ...